Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Best

Showing results (1161-1170 of 1,265) with videos related to

Pageof 127
Sort By:
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|November 28, 2019
D3 dopamine receptors and a missense mutation of fatty acid amide hydrolase linked in mouse and men: implication for addictionEsmaeil Mansouri, José N Nobrega, Matthew N Hill, et al.
Antimicrobial Agents and Chemotherapy|September 30, 2010
Total raltegravir concentrations in cerebrospinal fluid exceed the 50-percent inhibitory concentration for wild-type HIV-1David Croteau, Scott Letendre, Brookie M Best, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 20, 2013
Randomized trial of central nervous system-targeted antiretrovirals for HIV-associated neurocognitive disorderRonald J Ellis, Scott Letendre, Florin Vaida, et al.
Diagnostic Molecular Pathology : the American Journal of Surgical Pathology, Part B|May 27, 2003
Molecular differentiation of high- and moderate-grade human prostate cancer by cDNA microarray analysisCarolyn J M Best, Isabel M Leiva, Rodrigo F Chuaqui, et al.
Cell Reports|October 27, 2021
Mitophagy antagonism by ZIKV reveals Ajuba as a regulator of PINK1 signaling, PKR-dependent inflammation, and viral invasion of tissuesSanket S Ponia, Shelly J Robertson, Kristin L McNally, et al.
Nature Communications|October 25, 2024
Antibodies targeting the Crimean-Congo Hemorrhagic Fever Virus nucleoprotein protect via TRIM21Shanna S Leventhal, Thomas Bisom, Dean Clift, et al.
Nature Genetics|November 28, 2002
Post-analysis follow-up and validation of microarray experimentsRodrigo F Chuaqui, Robert F Bonner, Carolyn J M Best, et al.
Journal of Athletic Training|January 10, 2018
Normative Functional Performance Values in High School Athletes: The Functional Pre-Participation Evaluation ProjectJames A Onate, Cambrie Starkel, Daniel R Clifton, et al.
The Journal of Antimicrobial Chemotherapy|November 13, 2012
Darunavir is predominantly unbound to protein in cerebrospinal fluid and concentrations exceed the wild-type HIV-1 median 90% inhibitory concentrationDavid Croteau, Steven S Rossi, Brookie M Best, et al.
Journal of Strength and Conditioning Research|April 25, 2015
Long-term athletic development, part 2: barriers to success and potential solutionsRhodri S Lloyd, Jon L Oliver, Avery D Faigenbaum, et al.
Pageof 127

Showing results (1161-1170 of 1,265) with videos related to

Sort By:
Pageof 127
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|November 28, 2019
D3 dopamine receptors and a missense mutation of fatty acid amide hydrolase linked in mouse and men: implication for addictionEsmaeil Mansouri, José N Nobrega, Matthew N Hill, et al.
Antimicrobial Agents and Chemotherapy|September 30, 2010
Total raltegravir concentrations in cerebrospinal fluid exceed the 50-percent inhibitory concentration for wild-type HIV-1David Croteau, Scott Letendre, Brookie M Best, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 20, 2013
Randomized trial of central nervous system-targeted antiretrovirals for HIV-associated neurocognitive disorderRonald J Ellis, Scott Letendre, Florin Vaida, et al.
Diagnostic Molecular Pathology : the American Journal of Surgical Pathology, Part B|May 27, 2003
Molecular differentiation of high- and moderate-grade human prostate cancer by cDNA microarray analysisCarolyn J M Best, Isabel M Leiva, Rodrigo F Chuaqui, et al.
Cell Reports|October 27, 2021
Mitophagy antagonism by ZIKV reveals Ajuba as a regulator of PINK1 signaling, PKR-dependent inflammation, and viral invasion of tissuesSanket S Ponia, Shelly J Robertson, Kristin L McNally, et al.
Nature Communications|October 25, 2024
Antibodies targeting the Crimean-Congo Hemorrhagic Fever Virus nucleoprotein protect via TRIM21Shanna S Leventhal, Thomas Bisom, Dean Clift, et al.
Nature Genetics|November 28, 2002
Post-analysis follow-up and validation of microarray experimentsRodrigo F Chuaqui, Robert F Bonner, Carolyn J M Best, et al.
Journal of Athletic Training|January 10, 2018
Normative Functional Performance Values in High School Athletes: The Functional Pre-Participation Evaluation ProjectJames A Onate, Cambrie Starkel, Daniel R Clifton, et al.
The Journal of Antimicrobial Chemotherapy|November 13, 2012
Darunavir is predominantly unbound to protein in cerebrospinal fluid and concentrations exceed the wild-type HIV-1 median 90% inhibitory concentrationDavid Croteau, Steven S Rossi, Brookie M Best, et al.
Journal of Strength and Conditioning Research|April 25, 2015
Long-term athletic development, part 2: barriers to success and potential solutionsRhodri S Lloyd, Jon L Oliver, Avery D Faigenbaum, et al.
Pageof 127